Development and functional verification of CAR-T cells targeting CLL-1 / 中华血液学杂志
Chinese Journal of Hematology
;
(12): 102-106, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-929540
ABSTRACT
Objective:
To explore the development of a CAR-T cells targeting CLL-1 and verify its function.Methods:
The expression levels of CLL-1 targets in cell lines and primary cells were detected by flow cytometry. A CLL-1 CAR vector was constructed, and the corresponding lentivirus was prepared. After infection and activation of T cells, CAR-T cells targeting CLL-1 were produced and their function was verified in vitro and in vivo.Results:
CLL-1 was expressed in acute myeloid leukemia (AML) cell lines and primary AML cells. The transduction rate of the prepared CAR T cells was 77.82%. In AML cell lines and AML primary cells, CLL-1-targeting CAR-T cells significantly and specifically killed CLL-1-expressing cells. Compared to untransduced T cells, CAR-T cells killed target cells and secreted inflammatory cytokines, such as interleukin-6 and interferon-γ, at significantly higher levels (P<0.001) . In an in vivo human xenograft mouse model of AML, CLL-1 CAR-T cells also exhibited potent antileukemic activity and induced prolonged mouse survival compared with untransduced T cells [not reached vs 22 days (95%CI 19-24 days) , P=0.002].Conclusion:
CAR-T cells targeting CLL-1 have been successfully produced and have excellent functions.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Receptores Mitogénicos
/
Linfocitos T
/
Leucemia Mieloide Aguda
/
Citocinas
/
Inmunoterapia Adoptiva
/
Lectinas Tipo C
/
Línea Celular Tumoral
Límite:
Animales
/
Humanos
Idioma:
Chino
Revista:
Chinese Journal of Hematology
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS